Differing effects of two nitric oxide synthase inhibitors on experimental colitis

Area of Science:

• Gastroenterology
• Pharmacology
• Inflammation Research

Background:

• Nitric oxide synthase (NOS) plays a role in inflammatory conditions like colitis.
• Two main isoforms of NOS exist: constitutive (cNOS) and inducible (iNOS).
• The specific role of iNOS in trinitrobenzene sulfonic acid (TNBS)-induced colitis requires further elucidation.

Purpose of the Study:

• To investigate the therapeutic effects of inhibiting NOS isoforms in a rat model of colitis.
• To differentiate the roles of cNOS and iNOS in the pathogenesis of TNBS-induced colitis.

Main Methods:

• Colitis was induced in rats using trinitrobenzene sulfonic acid (TNBS) enema.
• Rats were treated with either NG-nitro-L-arginine (non-selective NOS inhibitor) or aminoguanidine (iNOS inhibitor) for one week.
• Colonic damage, body weight changes, and biochemical markers (TBARS, MPO) were assessed.

Main Results:

• Aminoguanidine treatment significantly attenuated TNBS-induced weight loss and colonic damage.
• NG-nitro-L-arginine treatment tended to worsen weight loss and colonic injury.
• Aminoguanidine significantly reduced colonic wet weight, TBARS, and MPO activity.

Conclusions:

• Inhibition of inducible nitric oxide synthase (iNOS) demonstrates therapeutic efficacy in experimental colitis.
• Selective iNOS inhibition offers a potential treatment strategy for colitis.
• Non-selective NOS inhibition may exacerbate colitis, highlighting the complex role of NOS isoforms.